C12N 5/0668
Mesenchymal stem cells from other natural sources
Official title: {Mesenchymal stem cells from other natural sources}
C12N5/0668 (Mesenchymal stem cells from other natural sources) appears on 376 US grants and 901 published applications in this corpus.
Search patents in C12N- Granted patents
- 376
- Published applications
- 901
- Assignees
- 490
- Inventors
- 1,604
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 12 |
| 2006 | 3 | 8 |
| 2007 | 0 | 8 |
| 2008 | 2 | 16 |
| 2009 | 3 | 15 |
| 2010 | 2 | 29 |
| 2011 | 11 | 33 |
| 2012 | 10 | 26 |
| 2013 | 14 | 47 |
| 2014 | 17 | 39 |
| 2015 | 30 | 40 |
| 2016 | 23 | 52 |
| 2017 | 30 | 52 |
| 2018 | 29 | 43 |
| 2019 | 26 | 57 |
| 2020 | 30 | 61 |
| 2021 | 29 | 60 |
| 2022 | 26 | 62 |
| 2023 | 20 | 81 |
| 2024 | 26 | 53 |
| 2025 | 24 | 61 |
| 2026 | 18 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for treating infectious diseases, comprising exosomes derived from thrombin-treated stem cells15 Sep 2026US 12,734,195 B2Samsung Life Public Welfare Foundation
- Immunotherapy method of targeted chemokine and cytokine delivery by mesenchymal stem cell8 Sep 2026US 12,729,372 B2Changen Therapeutics (Shanghai) Co., Ltd.
- Method for enhancing secretory function of mesenchymal stem cells and application thereof21 Jul 2026US 12,686,854 B2Shandong University
- Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof30 Jun 2026US 12,667,593 B2Amniotics AB
- Post-natal transplantation of factor VIII-expressing cells for treatment of hemophilia9 Jun 2026US 12,648,967 B2Children's Healthcare of Atlanta, Inc.
- Compositions and methods for the treatment of intestinal inflammation1 Oct 2026US 2026/0294973 A1Ann & Robert H. Lurie Children's Hospital of Chicago
- Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof1 Oct 2026US 2026/0294976 A1Amniotics AB
- Cell contamination assay17 Sep 2026US 2026/0275416 A1Sistemic Scotland Ltd
- Methods and compositions for enrichment of target cells3 Sep 2026US 2026/0256849 A1Pluri Biotech Ltd.
- Induction/differentiation medium for producing of mesenchymal stem cells and application thereof3 Sep 2026US 2026/0258367 A1Hunan Meibo Biomedical Co., Ltd
Most cited
By later US patents
- Mesenchymal stem cells for cartilage repair617US 5,906,934 AMorphoGen Pharmaceuticals, Inc. · 1999
- Mesenchymal stem cells for cartilage repair337US 6,214,369 B1MorphoGen Pharmaceuticals, Inc. · 2001
- Tissue-derived tissuegenic implants, and methods of fabricating and using same329US 8,883,210 B1Musculoskeletal Transplant Foundation · 2014
- Method of collecting placental stem cells151US 7,045,148 B2Anthrogenesis Corporation · 2006
- Immunomodulation using placental stem cells81US 7,682,803 B2Anthrogenesis Corporation · 2010